BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 14, 2002
View Archived Issues
Orally available thrombin inhibitor designed at LG Chem
Read More
Fujisawa reveals new series of potent human Y5 receptor antagonists
Read More
U.S. researchers successfully design soft cannabinoid analogues with potential in glaucoma Rx
Read More
Extended pharmacokinetics, pharmacodynamics confirmed for Albuferon in primates
Read More
PPARalpha may play an important role in angiotensin II-induced hypertension
Read More
Preclinical data for M-100240 reported at ASH meeting
Read More
Tadalafil: a new treatment option for men with erectile dysfunction
Read More
New data on rosiglitazone reported at the ASH meeting
Read More
Dose-dependent efficacy of the renin inhibitor aliskiren confirmed in hypertensive patients
Read More
Potential efficacy of adenosine analogue in atherosclerotic and inflammatory processes
Read More
Phase III data on Cidecin in complicated skin and soft tissue infections
Read More
Wyeth announces corrections to sirolimus prescribing information
Read More
COMT inhibitors useful for Rx of Parkinson's disease described in recent patent
Read More
(S)-Amlodipine enters phase II for treatment of hypertension
Read More
NCX-4016 inhibits vascular inflammation and platelet activation in phase I/IIa study
Read More
Biosearch reacquires North American rights to topical ramoplanin
Read More
Isotechnika and Roche focus ISAtx-247 development on transplantation
Read More
Enrollment completed in phase I trial of DAC:TI in hemodialysis patients with AV shunts
Read More
Genmab and ACE BioSciences to develop antibody therapeutics for infectious diseases
Read More
FDA advisory committee hands down positive opinion on acamprosate NDA
Read More
Bryostatin 1 gains E.U. orphan drug designation in esophageal cancer
Read More
Glycine transporter inhibitors and uses thereof claimed by Gliatech
Read More
Merck KGaA patents nicotinic acetylcholine receptor agonists
Read More
Benzamidine derivatives from Genentech inhibit serine proteases involved in thrombosis
Read More
Recent patent covers new agents for melatonergic system disorders
Read More
Antagonists at integrin receptors described for bone disorders, etc.
Read More
Merck presents new series of thrombin inhibitors
Read More